NEOGEN is your partner in the development and supply of generic and generic plus products.
NEOGEN was founded by a global team of professionals experienced in the different areas of the generic medicines industry. We provide our partners with quality, up to date product documentation and support to enable succesfull product launches across Europe.
NEOGEN has the necessary in-house capabilities and the most suitable cGMP manufacturers to offer a high and reliable quality launch at the most competitive prices.
NEOGEN is located in the heart of Europe with easy connections for its clients.
NEOGEN NV is part of the Alter group of companies, is based in Belgium, and its principle activity is the development, license and supply of generic products aimed at the hospital market. We have strong knowledge in several therapeutic fields including oncology, anti-infectives, gastro-intestinal, pain treatment, cardiology and CNS. We out-license products which have been either developed in-house at Neogen or through our sister companies within the Alter group (SP Pharma and Nordic Speciality Pharma), as well as products made available to us through collaborative agreements with other product developers.
We are a small expert team of experienced professionals, who know the generic and branded industries well, have experience of managing license and supply partnerships with third parties and are open to development proposals which bring mutual benefit.